Back to video list Back to Home Eptinezumab – an efficacious, fast and sustained anti-CGRP monoclonal antibody therapy for preventive migraine treatment You may also like Alzheimer's Disease Parkinson's Disease Article Winter poses climatic and cultural challenges Depression Congress highlights Article Predicting antidepressant response – problems and promises Schizophrenia Article Treatment-resistant schizophrenia – results of a survey on its clinical impact and therapeutic strategies Schizophrenia Satellite symposium Article Key considerations for women living with schizophrenia